サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1742512

プレフィルドシリンジの世界市場：シリンジ組成別、使用法別、デザイン別、用途別、地域別、機会、予測、2018年～2032年

Prefilled Syringes Market Assessment, By Syringe Composition, By Usability, By Design, By Application, Region, Opportunities and Forecast, 2018-2032F

出版日
ページ情報
英文 225 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.71円
プレフィルドシリンジの世界市場：シリンジ組成別、使用法別、デザイン別、用途別、地域別、機会、予測、2018年～2032年
出版日: 2025年06月06日
発行: Market Xcel - Markets and Data
ページ情報: 英文 225 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプレフィルドシリンジの市場規模は、予測期間の2025年～2032年に10.54%のCAGRで拡大し、2024年の79億4,000万米ドルから2032年には177億米ドルに成長すると予測されています。プレフィルドシリンジ市場は、糖尿病患者、がん、関節リウマチ、多発性硬化症、心血管障害などの慢性疾患の有病率の上昇により急成長しています。米国がん協会によると、米国では2025年に204万1,910人の新規がん患者と61万8,120人のがん死亡者が発生すると予測されています。

プレフィルドシリンジ市場は、正確で無菌の送達を必要とする生物製剤やバイオシミラーの需要増に牽引されて急成長しています。プレフィルドシリンジの使用は、市販のバイアルから別の容器に薬剤を移し替える無数の人員による汚染のリスクを低減します。また、投与精度が向上し、投与が容易で、簡便であるため患者の利便性も向上します。糖尿病や自己免疫疾患のような慢性疾患の増加を考慮すると、安全設計注射器、自動注射器、公的支援を受けた補助送達システムの使用といった他の技術に加え、プレフィルドシリンジはより広範な採用が見込まれています。

さらに、業界の大手企業は協力的な活動に取り組んでおり、市場の拡大を後押ししています。例えば、2023年3月、Stevanto Group S.p.A.はRecipharm ABと提携し、Recipharmのソフトミスト吸入器に使用されるプレフィルドシリンジを開発・製造するための革新的な一次包装を提供しました。

当レポートでは、世界のプレフィルドシリンジ市場について調査し、市場の概要とともに、シリンジ組成別、使用法別、デザイン別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界のプレフィルドシリンジ市場の見通し、2018年～2032年

  • 市場規模分析と予測
  • 市場シェア分析と予測
    • シリンジ組成別
      • ガラスプレフィルドシリンジ
      • プラスチック（ポリマー）プレフィルドシリンジ
    • 使用法別
      • ディスポーザブルプレフィルドシリンジ
      • 再利用型プレフィルドシリンジ
    • デザイン別
      • シングルチャンバープレフィルドシリンジ
      • デュアルチャンバープレフィルドシリンジ
      • マルチチャンバープレフィルドシリンジ
    • 用途別
      • アナフィラキシー
      • 糖尿病
      • 自己免疫疾患
      • 腫瘍科
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • 南米
      • 中東・アフリカ
    • 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
  • 2024年の市場マップ分析

第6章 北米のプレフィルドシリンジ市場の見通し、2018年～2032年

  • 市場規模分析と予測
  • 市場シェア分析と予測
  • 国別市場評価
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のプレフィルドシリンジ市場の見通し、2018年～2032年

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第8章 アジア太平洋のプレフィルドシリンジ市場の見通し、2018年～2032年

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第9章 南米のプレフィルドシリンジ市場の見通し、2018年～2032年

  • ブラジル
  • アルゼンチン

第10章 中東・アフリカのプレフィルドシリンジ市場の見通し、2018年～2032年

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第11章 需要供給分析

第12章 輸出入の分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 PESTLE分析

第16章 価格分析

第17章 市場力学

  • 市場の促進要因
  • 市場の課題

第18章 市場動向と発展

第19章 規制の枠組み

  • 規制当局の承認

第20章 特許の情勢

第21章 ケーススタディ

第22章 競合情勢

  • 市場リーダートップ5の競合マトリックス
  • 参入企業トップ5のSWOT分析
  • 市場の主要企業トップ10の情勢
    • Becton, Dickinson, and Company
    • Gerresheimer AG
    • SCHOTT Pharma
    • Terumo Corporation
    • West Pharmaceutical Services, Inc.
    • NIPRO EUROPE GROUP COMPANIES
    • AptarGroup, Inc.
    • Baxter International Inc.
    • Catalent, Inc.
    • Stevanato Group

第23章 戦略的提言

第24章 調査会社について・免責事項

図表

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 3. Global Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 4. Global Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 5. Global Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 6. Global Prefilled Syringes Market Share (%), By Region, 2018-2032F
  • Figure 7. North America Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 8. North America Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 9. North America Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 10. North America Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 11. North America Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 12. North America Prefilled Syringes Market Share (%), By Country, 2018-2032F
  • Figure 13. United States Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 14. United States Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 15. United States Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 16. United States Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 17. United States Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 18. Canada Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 19. Canada Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 20. Canada Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 21. Canada Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 22. Canada Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 23. Mexico Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Mexico Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 25. Mexico Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 26. Mexico Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 27. Mexico Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 28. Europe Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Europe Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 30. Europe Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 31. Europe Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 32. Europe Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 33. Europe Prefilled Syringes Market Share (%), By Country, 2018-2032F
  • Figure 34. Germany Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 35. Germany Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 36. Germany Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 37. Germany Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 38. Germany Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 39. France Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 40. France Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 41. France Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 42. France Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 43. France Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 44. Italy Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Italy Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 46. Italy Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 47. Italy Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 48. Italy Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 49. United Kingdom Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 50. United Kingdom Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 51. United Kingdom Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 52. United Kingdom Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 53. United Kingdom Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 54. Russia Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 55. Russia Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 56. Russia Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 57. Russia Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 58. Russia Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 59. Netherlands Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 60. Netherlands Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 61. Netherlands Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 62. Netherlands Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 63. Netherlands Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 64. Spain Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. Spain Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 66. Spain Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 67. Spain Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 68. Spain Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 69. Turkey Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Turkey Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 71. Turkey Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 72. Turkey Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 73. Turkey Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 74. Poland Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 75. Poland Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 76. Poland Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 77. Poland Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 78. Poland Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 79. South America Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 80. South America Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 81. South America Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 82. South America Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 83. South America Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 84. South America Prefilled Syringes Market Share (%), By Country, 2018-2032F
  • Figure 85. Brazil Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 86. Brazil Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 87. Brazil Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 88. Brazil Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 89. Brazil Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 90. Argentina Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Argentina Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 92. Argentina Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 93. Argentina Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 94. Argentina Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 95. Asia-Pacific Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 96. Asia-Pacific Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 97. Asia-Pacific Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 98. Asia-Pacific Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 99. Asia-Pacific Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 100. Asia-Pacific Prefilled Syringes Market Share (%), By Country, 2018-2032F
  • Figure 101. India Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 102. India Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 103. India Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 104. India Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 105. India Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 106. China Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. China Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 108. China Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 109. China Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 110. China Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 111. Japan Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 112. Japan Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 113. Japan Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 114. Japan Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 115. Japan Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 116. Australia Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 117. Australia Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 118. Australia Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 119. Australia Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 120. Australia Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 121. Vietnam Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 122. Vietnam Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 123. Vietnam Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 124. Vietnam Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 125. Vietnam Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 126. South Korea Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 127. South Korea Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 128. South Korea Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 129. South Korea Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 130. South Korea Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 131. Indonesia Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 132. Indonesia Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 133. Indonesia Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 134. Indonesia Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 135. Indonesia Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 136. Philippines Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 137. Philippines Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 138. Philippines Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 139. Philippines Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 140. Philippines Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 141. Middle East & Africa Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 142. Middle East & Africa Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 143. Middle East & Africa Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 144. Middle East & Africa Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 145. Middle East & Africa Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 146. Middle East & Africa Prefilled Syringes Market Share (%), By Country, 2018-2032F
  • Figure 147. Saudi Arabia Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 148. Saudi Arabia Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 149. Saudi Arabia Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 150. Saudi Arabia Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 151. Saudi Arabia Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 152. UAE Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 153. UAE Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 154. UAE Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 155. UAE Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 156. UAE Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 157. South Africa Prefilled Syringes Market, By Value, In USD Billion, 2018-2032F
  • Figure 158. South Africa Prefilled Syringes Market Share (%), By Syringe Composition, 2018-2032F
  • Figure 159. South Africa Prefilled Syringes Market Share (%), By Usability, 2018-2032F
  • Figure 160. South Africa Prefilled Syringes Market Share (%), By Design, 2018-2032F
  • Figure 161. South Africa Prefilled Syringes Market Share (%), By Application, 2018-2032F
  • Figure 162. By Syringe Composition Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 163. By Usability Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 164. By Design Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 165. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX13258

Global prefilled syringes market is projected to witness a CAGR of 10.54% during the forecast period 2025-2032, growing from USD 7.94 billion in 2024 to USD 17.70 billion in 2032. Prefilled syringes market is rapidly growing due to increased prevalence of chronic diseases such as diabetics, cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular disorder. According to the American Cancer Society, 2,041,910 new cancer cases and 618,120 cancer death are predicted to occur in the United States in 2025.

The prefilled syringes market is witnessing rapid growth driven by the increased demand for biologics and biosimilars that require accurate and sterile delivery. The use of prefilled syringes reduces the risk of contamination from countless personnel transferring medications from commercial vials to another container. They also achieve better dosing accuracy, easy administration, and convenience for patients because of their simplicity. Given the increase of chronic conditions such as diabetes and autoimmune conditions, prefilled syringes among other technologies such as safety-engineered syringes, auto-injectors, and the use of aided delivery systems which are publicly supported, are expected to see wider adoption.

Additionally, the leading players in the industry are engaging in collaborative activities, bolstering the market's expansion. For instance, in March 2023, Stevanto Group S.p.A. partnered with Recipharm AB to provide innovative primary packaging to develop and produce pre-filled syringes to be used in Recipharm's soft mist inhalers.

Increasing Awareness Supports Market Expansion

Pre-filled syringes deliver extra safety and a reduced risk of contamination because a pharmacy is not required to handle the preparation of medication. The drug is pre-measured in the syringe and factory-sealed, ensuring sterility, and now in an evaluated state for use that is acutely important for clinical and homecare settings. Many prefilled syringes are equipped with a range of safety features such as retractable or shielded needles, which offer risk-reduction solutions for needlestick injuries and accidental reuse. The immediate visibility of tamper-evident features and labelling decreases medication identification errors, in accordance with the prescribing standards recommendations to provide medications in ready-to-administer, or unit dose dispatch forms, thereby improving patient safety.

As the awareness about prefilled syringes increases, leading pharmaceutical companies are focusing on packaging their products in prefilled syringes to ensure safety and physician convenience. For instance, in May 2023, Nexus Pharmaceuticals, Inc. received FDA approval for EMERPHED, indicated for treating clinically significant hypotension during the administration of any type of anesthesia. The prefilled, ready-to-administer syringes provide some measures of protection against danger in critical care situations.

Innovations Support Market Expansion

The market for prefilled syringes is undergoing transformative innovation fueled by the need for accurate biological drug delivery, patient safety, and affordable healthcare. New material science is ensuring the production of more stable and drug-compatible glass and polymers, while the use of smart technology is allowing for dose tracking and adherence monitoring through IoT-connected devices. Furthermore, safety enabling measures such as auto-retractable needle and passive shielding are being designed for addressing needlestick risks as well as user-centered designs that facilitate self-administration for patients with chronic conditions. All resulting in the acceleration of innovative devices including prefilled syringes because of regulatory pressures for safer delivery systems and the growing need for preparedness for pandemics, as well as green initiatives promoting sustainable and biodegradable materials.

Additionally, in order to ensure safe delivery, leading market players are focusing on launching prefilled syringe identification traceability solutions. For instance, in January 2025, Becton, Dickinson and Company launched the BD iDFill individual pre-fillable syringe identification traceability solution to enable unit level traceability throughout the lifecycle of prefilled syringes.

Diabetics Holds the Largest Share in Prefilled Syringes Market

Diabetes is a chronic disease that requires insulin and injectable therapies for a long duration, and thus, the patient population prefers mode of administration that are easy to use, safe, and deliver accurate dosing. As the world moves towards advanced therapies such as GLP-1 receptor agonists, and more concentrated insulins, the requirement for advanced solutions for administering insulin is increasing. Increasing diabetes prevalence across the globe, along with advancements in drug delivery are providing lucrative growth opportunities for the market. The segment is expected to maintain its status as the largest segment due to increasing innovations and growing efforts of various regulatory bodies to effectively combat the increasing threat of diabetes, driving the growth of the prefilled syringes market. For instance, in July 2024, the FDA approved Vabysmo single-dose prefilled syringe for the treatment of wet age-related macular degeneration, diabetic macular edema and retinal vein occlusion. Such approvals are expected to provide lucrative growth opportunities for the market.

North America Dominates the Prefilled Syringes Market

The prefilled syringes market is largely dominated by North America, it benefits from advanced healthcare infrastructure, high prevalence of chronic diseases, and strong presence of some of the world's leading pharmaceutical and biotech companies. Due to the increasing patient and provider awareness about the safety and convenience offered by pre-filled syringes, the market is witnessing rapid expansion in the region. North America also has regulatory support (largely by the FDA) for products, so there are faster timelines for approval and faster timelines related to innovation (such as combining technologies with prefilled syringes). For instance, in March 2024, Schott Pharma invested USD 371 million in a new prefilled syringe manufacturing plant in North Carolina. The aim of this plant is to triple the United States supply of glass and polymer syringes to be able to meet the growing demand.

Impact of U.S. Tariffs on Prefilled Syringes Market

Rising Production Costs: Tariffs on foreign raw materials such as glass, rubber stoppers, and plastic pieces will lead to increased production costs. Higher costs will be transferred to the pharmaceutical companies, hospitals, and patients.

Disruption in Supply Chain: The majority of components to make prefilled syringes come from China, Germany, and other countries where tariffs are applied. Delays in these imports can lead to shortages that can affect the delivery of vaccines or biologic drugs.

Increased Interest in Localized Products: Companies will start to look at manufacturing in the United States for more components to avoid tariffs, but this will take time and investment. Non-tariff countries (mostly India, Southeast Asia) may pick up market share from suppliers in other parts of the world.

Increased Costs for End-users: Hospitals, clinics, and patients will pay more for prefilled syringes and injectable drugs. Could be a strain on healthcare budgets and particularly damaging for developing markets.

Lower Innovation: The money that would be used for research and development will take a backseat due to increased import costs. Delayed timelines for next generation of prefilled syringe technologies, such as smart injectors.

Key Players Landscape and Outlook

The rapid rise in biologic drugs and biosimilars requiring exact, sterile delivery in compact devices has made prefilled syringes critical to preserving product integrity and efficacy. Global consistency on vaccination and pandemic preparedness fosters broader adoption of prefilled syringe systems, which are easy to use and improve accuracy of dosing among large groups. The continued focus on drug delivery efficiency and related reduction in healthcare expenditure will continue to drive innovation in smart devices, some with dose-tracking features. Sustainability goals also encourage stakeholder investment in greener materials and designs. With all these combined factors, the outlook for prefilled syringes market growth is compelling.

Moreover, leading market players are focusing on launching new products and technologies to expand their presence in the market. For instance, in January 2025, NIPRO EUROPE GROUP COMPANIES introduced D2F Pre-fillable Glass Syringe System - Silicone Oil-Free to meet the unique and demanding requirements of sensitive drugs and the pharmaceutical industry.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of the U.S. Tariffs

4. Executive Summary

5. Global Prefilled Syringes Market Outlook, 2018-2032F

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Syringe Composition
      • 5.2.1.1. Glass Prefilled Syringes
      • 5.2.1.2. Plastic (Polymer) Prefilled Syringes
    • 5.2.2. By Usability
      • 5.2.2.1. Disposable Prefilled Syringes
      • 5.2.2.2. Reusable Prefilled Syringes
    • 5.2.3. By Design
      • 5.2.3.1. Single-Chamber Prefilled Syringes
      • 5.2.3.2. Dual-Chamber Prefilled Syringes
      • 5.2.3.3. Multi-Chambered Prefilled Syringes
    • 5.2.4. By Application
      • 5.2.4.1. Anaphylaxis
      • 5.2.4.2. Diabetes
      • 5.2.4.3. Autoimmune Diseases
      • 5.2.4.4. Oncology
      • 5.2.4.5. Others
    • 5.2.5. By Region
      • 5.2.5.1. North America
      • 5.2.5.2. Europe
      • 5.2.5.3. Asia-Pacific
      • 5.2.5.4. South America
      • 5.2.5.5. Middle East and Africa
    • 5.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 5.3. Market Map Analysis, 2024
    • 5.3.1. By Syringe Composition
    • 5.3.2. By Usability
    • 5.3.3. By Design
    • 5.3.4. By Application
    • 5.3.5. By Region

6. North America Prefilled Syringes Market Outlook, 2018-2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Syringe Composition
      • 6.2.1.1. Glass Prefilled Syringes
      • 6.2.1.2. Plastic (Polymer) Prefilled Syringes
    • 6.2.2. By Usability
      • 6.2.2.1. Disposable Prefilled Syringes
      • 6.2.2.2. Reusable Prefilled Syringes
    • 6.2.3. By Design
      • 6.2.3.1. Single-Chamber Prefilled Syringes
      • 6.2.3.2. Dual-Chamber Prefilled Syringes
      • 6.2.3.3. Multi-Chambered Prefilled Syringes
    • 6.2.4. By Application
      • 6.2.4.1. Anaphylaxis
      • 6.2.4.2. Diabetes
      • 6.2.4.3. Autoimmune Diseases
      • 6.2.4.4. Oncology
      • 6.2.4.5. Others
    • 6.2.5. By Country Share
      • 6.2.5.1. United States
      • 6.2.5.2. Canada
      • 6.2.5.3. Mexico
  • 6.3. Country Market Assessment
    • 6.3.1. United States Prefilled Syringes Market Outlook, 2018-2032F*
      • 6.3.1.1. Market Size Analysis & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share Analysis & Forecast
        • 6.3.1.2.1. By Syringe Composition
          • 6.3.1.2.1.1. Glass Prefilled Syringes
          • 6.3.1.2.1.2. Plastic (Polymer) Prefilled Syringes
        • 6.3.1.2.2. By Usability
          • 6.3.1.2.2.1. Disposable Prefilled Syringes
          • 6.3.1.2.2.2. Reusable Prefilled Syringes
        • 6.3.1.2.3. By Design
          • 6.3.1.2.3.1. Single-Chamber Prefilled Syringes
          • 6.3.1.2.3.2. Dual-Chamber Prefilled Syringes
          • 6.3.1.2.3.3. Multi-Chambered Prefilled Syringes
        • 6.3.1.2.4. By Application
          • 6.3.1.2.4.1. Anaphylaxis
          • 6.3.1.2.4.2. Diabetes
          • 6.3.1.2.4.3. Autoimmune Diseases
          • 6.3.1.2.4.4. Oncology
          • 6.3.1.2.4.5. Others
    • 6.3.2. Canada
    • 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Prefilled Syringes Market Outlook, 2018-2032F

  • 7.1. Germany
  • 7.2. France
  • 7.3. Italy
  • 7.4. United Kingdom
  • 7.5. Russia
  • 7.6. Netherlands
  • 7.7. Spain
  • 7.8. Turkey
  • 7.9. Poland

8. Asia-Pacific Prefilled Syringes Market Outlook, 2018-2032F

  • 8.1. India
  • 8.2. China
  • 8.3. Japan
  • 8.4. Australia
  • 8.5. Vietnam
  • 8.6. South Korea
  • 8.7. Indonesia
  • 8.8. Philippines

9. South America Prefilled Syringes Market Outlook, 2018-2032F

  • 9.1. Brazil
  • 9.2. Argentina

10. Middle East and Africa Prefilled Syringes Market Outlook, 2018-2032F

  • 10.1. Saudi Arabia
  • 10.2. UAE
  • 10.3. South Africa

11. Demand Supply Analysis

12. Import and Export Analysis

13. Value Chain Analysis

14. Porter's Five Forces Analysis

15. PESTLE Analysis

16. Pricing Analysis

17. Market Dynamics

  • 17.1. Market Drivers
  • 17.2. Market Challenges

18. Market Trends and Developments

19. Regulatory Framework

  • 19.1. Regulatory Approvals

20. Patent Landscape

21. Case Studies

22. Competitive Landscape

  • 22.1. Competition Matrix of Top 5 Market Leaders
  • 22.2. SWOT Analysis for Top 5 Players
  • 22.3. Key Players Landscape for Top 10 Market Players
    • 22.3.1. Becton, Dickinson, and Company
      • 22.3.1.1. Company Details
      • 22.3.1.2. Key Management Personnel
      • 22.3.1.3. Products and Services
      • 22.3.1.4. Financials (As Reported)
      • 22.3.1.5. Key Market Focus and Geographical Presence
      • 22.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 22.3.2. Gerresheimer AG
    • 22.3.3. SCHOTT Pharma
    • 22.3.4. Terumo Corporation
    • 22.3.5. West Pharmaceutical Services, Inc.
    • 22.3.6. NIPRO EUROPE GROUP COMPANIES
    • 22.3.7. AptarGroup, Inc.
    • 22.3.8. Baxter International Inc.
    • 22.3.9. Catalent, Inc.
    • 22.3.10. Stevanato Group

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

23. Strategic Recommendations

24. About Us and Disclaimer